Sitagliptin Combo Study.

Trial Profile

Sitagliptin Combo Study.

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Sep 2013

At a glance

  • Drugs JNJ 38431055 (Primary) ; Sitagliptin
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 02 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Mar 2010 Planned number of patients changed from 20 to 2 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top